Safety, tolerability, and immunogenicity of WGc-043 in subjects with EBV-positive cancers: Results from an investigator-initiated trial.
| Published in: | Journal of Clinical Oncology Vol. 42; pp. 139 - 159 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Journal Article |
| Published: |
American Society of Clinical Oncology
2024 Supplement
|
| Online Access: | View this record in EBSCOhost |